RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemia.

Gassner, FJ; Zaborsky, N; Buchumenski, I; Levanon, EY; Gatterbauer, M; Schubert, M; Rauscher, S; Hebenstreit, D; Nadeu, F; Campo, E; Egle, A; Greil, R; Geisberger, R Leukemia. 2021; 35(4):1053-1063

Evaluation of circulating cell-free KRAS mutational status as a molecular monitoring tool in patients with pancreatic cancer.

Schlick, K; Markus, S; Huemer, F; Ratzinger, L; Zaborsky, N; Clemens, H; Neureiter, D; Neumayer, B; Beate, AS; Florian, S; Martin, V; Grundbichler, M; Weiss, L; Melchardt, T; Greil, R; Egle, A; Pancreatology. 2021; 21(8):1466-1471

A Lower CD4 Count Predicts Most Causes of Death except Cardiovascular Deaths. The Austrian HIV Cohort Study.

Leierer, G; Rieger, A; Schmied, B; Sarcletti, M; Oellinger, A; Wallner, E; Egle, A; Kanatschnig, M; Zoufaly, A; Atzl, M; Rappold, M; El-Khatib, Z; Ledergerber, B; Zangerle, R; Grp INT J ENV RES PUB HE. 2021; 18(23):

Evidence for Non-Cancer-Specific T Cell Exhaustion in the Tcl1 Mouse Model for Chronic Lymphocytic Leukemia.

Parigger, T; Gassner, FJ; Scherhaufl, C; Abu Bakar, A; Hopner, JP; Hodlmoser, A; Steiner, M; Catakovic, K; Geisberger, R; Greil, R; Zaborsky, N INT J MOL SCI. 2021; 22(13):

Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations.

Wierda, WG; Rawstron, A; Cymbalista, F; Badoux, X; Rossi, D; Brown, JR; Egle, A; Abello, V; Ceballos, EC; Herishanu, Y; Mulligan, SP; Niemann, CU; Diong, CP; Soysal, T; Suzuki, R; Tran, HTT; Wu, SJ; Owen, C; Stilgenbauer, S; Ghia, P; Hillmen, P LEUKEMIA. 2021; 35(11): 3059-3072.

The interrelationship of smoking, CD4+ cell count, viral load and cancer in persons living with HIV.

The RESPOND study group AIDS. 2021; 35(5): 747-757.

Sex-Based Clinical Outcome in Advanced NSCLC Patients Undergoing PD-1/PD-L1 Inhibitor Therapy-A Retrospective Bi-Centric Cohort Study.

Lang, D; Brauner, A; Huemer, F; Rinnerthaler, G; Horner, A; Wass, R; Brehm, E; Kaiser, B; Greil, R; Lamprecht, B; Cancers (Basel). 2021; 14(1):

Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry

Gampenrieder, SP; Rinnerthaler, G; Tinchon, C; Petzer, A; Balic, M; Heibl, S; Schmitt, C; Zabernigg, AF; Egle, D; Sandholzer, M; Singer, CF; Roitner, F; Hager, C; Andel, J; Hubalek, M; Knauer, M; Greil, R BREAST CANCER RES. 2021; 23(1): 112

Recent Advances in Pancreatic Cancer: Novel Prognostic Biomarkers and Targeted Therapy-A Review of the Literature.

Schlick, K; Kiem, D; Greil, R; Biomolecules. 2021; 11(10):

Sustained response to brigatinib in a patient with refractory metastatic pheochromocytoma harboring R1192P anaplastic lymphoma kinase mutation: a case report from the Austrian Group Medical Tumor Therapy next-generation sequencing registry and discussion of the literature.

Heregger, R; Huemer, F; Hutarew, G; Hecht, S; Cheveresan, L; Kotzot, D; Schamschula, E; Rinnerthaler, G; Melchardt, T; Weiss, L; Greil, R; ESMO Open. 2021; 6(4):100233